Front Page Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity? Yahoo Finance · 1d ago Read the full story at Yahoo Finance →